Victory Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
24,649
+14,108
| +134% | +$209K | ﹤0.01% | 2112 |
|
|
2025
Q1 | $189K | Buy |
10,541
+78
| +0.7% | +$1.4K | ﹤0.01% | 2234 |
|
|
2024
Q4 | $182K | Buy |
+10,463
| New | +$182K | ﹤0.01% | 2256 |
|
|
2022
Q4 | – | Sell |
-17,547
| Closed | -$432K | – | 2707 |
|
|
2022
Q3 | $432K | Sell |
17,547
-1,092
| -6% | -$26.9K | ﹤0.01% | 2111 |
|
|
2022
Q2 | $452K | Buy |
18,639
+480
| +3% | +$11.6K | ﹤0.01% | 2100 |
|
|
2022
Q1 | $456K | Buy |
18,159
+10,410
| +134% | +$261K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $241K | Buy |
+7,749
| New | +$241K | ﹤0.01% | 2437 |
|
|
2021
Q2 | – | Sell |
-8,608
| Closed | -$215K | – | 2812 |
|
|
2021
Q1 | $215K | Buy |
+8,608
| New | +$215K | ﹤0.01% | 2510 |
|
|
2020
Q2 | – | Sell |
-10,008
| Closed | -$146K | – | 3236 |
|
|
2020
Q1 | $146K | Buy |
+10,008
| New | +$146K | ﹤0.01% | 2420 |
|
|
2019
Q4 | – | Sell |
-5,149
| Closed | -$60K | – | 3241 |
|
|
2019
Q3 | $60K | Buy |
+5,149
| New | +$60K | ﹤0.01% | 2607 |
|